Introduction
Rabepar LS Capsule by Astemax Biotech features an advanced enteric-coated formula with rabeprazole and levosulpiride sustained-release, ensuring protected delivery for maximum acid suppression and motility enhancement. This enteric coating safeguards the active ingredients from stomach acid breakdown, releasing them precisely in the intestines for superior absorption and prolonged efficacy.
Enteric-Coated Design
The enteric coating on rabeprazole pellets prevents premature dissolution in the acidic stomach environment, allowing targeted release in the alkaline small intestine. Combined with levosulpiride SR, this formulation maintains steady therapeutic levels over 24 hours. It minimizes gastric irritation while optimizing bioavailability for consistent GERD management.
Enhanced Benefits
-
Delivers potent proton pump inhibition without acid degradation for faster heartburn relief.
-
Boosts gastric emptying and reduces reflux through protected, sustained dual action.
-
Improves patient compliance with once-daily dosing and reduced side effect profile.
Quality Excellence
Manufactured in Astemax’s WHO-GMP certified facilities, Rabepar LS enteric-coated capsules uphold global standards for purity and stability. Ethical marketing emphasizes clinically validated benefits for trusted physician recommendations.
Mechanism Advantage
Enteric protection enables rabeprazole to fully inhibit parietal cell pumps, cutting acid by up to 90%, while levosulpiride enhances sphincter function. This precise intestinal release ensures peak efficiency against dyspepsia and ulcers.
Dosage Guidance
Take one capsule daily before breakfast, swallowed whole. Consult physicians for chronic use or special conditions. Store below 30°C in dry conditions.
